ClinicalTrials.Veeva

Menu

Effects of n-3 Polyunsaturated Fatty Acids and Antioxidants on Postprandial Hyperlipidemia and Vascular Function in Men

L

Laval University

Status and phase

Completed
Phase 3
Phase 2

Conditions

Vasodilation
Cardiovascular Diseases

Treatments

Behavioral: Nutrition

Study type

Interventional

Funder types

Other

Identifiers

NCT00296595
MOP-64438

Details and patient eligibility

About

Diet has long been used as a way to provide enough nutrients to an individual in order to meet metabolic requirements. However, recent scientific advancements have suggested that beyond meeting nutrition needs, diet may also be health promoting through the modulation of various body functions. In a way, the role of nutrition has evolved from hunger satisfaction and maintenance of body integrity to the promotion of a state of well-being and prevention of important chronic diseases such as cancer, diabetes and cardiovascular disease (CVD). In recent years, n-3 polyunsaturated fatty acids (PUFA) have attracted much attention as consumption of a n-3 PUFA rich diet has been reported to reduce CVD risk. However, n-3 PUFA are also highly susceptible to free radical damage and therefore could be unable to fully exert their health benefits under an oxidative stress condition. The general objective of the present application is to investigate the mechanisms by which n-3 PUFA improve cardiovascular health in abdominal obesity and explore the potential of dietary antioxidants to modulate these effects in individuals at high risk of oxidative stress. For that purpose, we plan to study the changes in fasting and postprandial plasma lipoprotein-lipid levels, markers of lipid and lipoprotein oxidation, inflammation and endothelial dysfunction following 12 weeks of n-3 PUFA supplementation with or without low-calorie cranberry juice cocktail (as a source of antioxidants) in a group of 160 men. We feel that the present study will broaden our understanding of the physiological mechanisms underlying the beneficial effects of consuming unsaturated fatty acids and give further insights on the role of antioxidants in preserving and potentiating these cardiovascular health benefits.

Enrollment

99 patients

Sex

Male

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Waist circumference > 90 cm
  • Fasting triglycerides > 1.7 mmol/L
  • No use (ever) of medications for the treatment for dyslipidemia or hypertension

Exclusion criteria

  • Alcohol consumption > 1 drink per day i.e ~15 g of alcohol/day or the equivalent of 1 beer (12 oz or 341 mL), 1 glass of wine (4 oz or 125 mL) or 1 ounce (30 mL) of liquor.
  • Chronic use of supplements (vitamins, minerals or flavonoids)
  • Body mass index > 35 kg/m2
  • Chronic diseases: CHD, diabetes, etc.
  • Smokers (1 or more cigarette/day)
  • Dyslipidemia secondary to renal insufficiency, hypothyroidism or others
  • Any prior or current use of medications known to affect lipoprotein-lipid metabolism (e.g. statins, fibrates), endothelial function (hypotensive drugs). Use (ever) of anticoagulant drugs (e.g. warfarin) because of possible detrimental interaction with the consumption of cranberry juice. Current or recent (<2 weeks) use of anti-inflammatory drugs Note: If for any reason, a subject would have to go an any of these drugs during the protocol, they would be automatically dropped from the study.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

99 participants in 4 patient groups, including a placebo group

Placebo
Placebo Comparator group
Description:
Placebo capsules + 500 mL/day of placebo juice
Treatment:
Behavioral: Nutrition
Cranberry Juice
Experimental group
Description:
Placebo capsules + 500 mL/day of cranberry juice
Treatment:
Behavioral: Nutrition
Fish Oil
Experimental group
Description:
2 g/day of fish oil + 500 mL/day of placebo juice
Treatment:
Behavioral: Nutrition
Cranberry Juice + Fish Oil
Experimental group
Description:
2 g/day of fish oil + 500 mL/day of cranberry juice
Treatment:
Behavioral: Nutrition

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems